Latest Share Purchase Plans News

Iltani Resources has raised $1.8 million through a share placement and launched a $1 million Share Purchase Plan to fund exploration at its promising Orient Silver-Indium Project.

Atomo Diagnostics has released a Target Market Determination for a new capital raising involving options and shares, including a $1 million Share Purchase Plan and placement offer. The move targets eligible Australian shareholders and aims to bolster the company’s financial position amid a speculative investment environment.

Atomo Diagnostics Limited has announced a capital raising initiative comprising a Share Purchase Plan (SPP) and a Placement, aiming to raise up to $1 million through the SPP and additional funds via a Placement, subject to shareholder approval at a June 23 meeting.

IMEXHS Limited reported robust FY24 growth and launched its AI-enabled medical imaging platform Aquila+, setting the stage for expected profitability and accelerated revenue in 2025.

VHM Limited has opened a $2 million Share Purchase Plan at 25 cents per share, matching its recent placement price, to support the Goschen Project ahead of a final investment decision. Eligible shareholders in Australia and New Zealand can subscribe up to $30,000, with the offer closing on June 10.

Empire Energy Group has launched a $28 million equity raise to fund critical development activities at its Beetaloo Basin shale gas project, aiming for first gas sales in 2025. The capital will support fracture stimulation, flow testing, and installation of the Carpentaria Gas Plant.

Empire Energy has successfully raised $28 million through a placement and launched a $3 million Share Purchase Plan to fund critical development of its Carpentaria-5H well in the Beetaloo Sub-basin.

Appen Limited reports a strong financial turnaround in FY24, driven by growth outside Google and a focus on generative AI, while seeking shareholder approval for key governance and remuneration measures.

MedAdvisor Limited has successfully closed its Share Purchase Plan, raising $2.668 million-exceeding its $2 million target-and plans an upcoming shareholder meeting to approve director share issuances.

Euro Manganese Inc. reported a net loss of CAD 9.174 million for the half-year ending March 31, 2025, while making significant progress on its Chvaletice Manganese Project, including securing key permits and strategic status under EU and Czech frameworks. The company’s development hinges on completing a crucial private placement and share purchase plan to sustain operations.

Euro Manganese advances its Chvaletice manganese project with key regulatory approvals, leadership appointments, and a $9.8 million capital raise, while reporting a narrowed Q3 net loss.

Euro Manganese Inc. reported a $9.17 million net loss for the six months ending March 31, 2025, while advancing its Chvaletice Manganese Project and pursuing a critical $11.2 million capital raise. The company’s future hinges on successful financing and project milestones amid ongoing development costs.